 | • レポートコード：D005-01039 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、1型糖尿病の世界市場を広く調査・分析し、今後の市場展望をまとめております。1型糖尿病の種類別市場規模（速効性、長時間作用性、プレミックス）、用途別市場規模（病院、診断クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott、AstraZeneca、BD、Bayer、Pfizer、Eli Lilly、Smiths Medical、Merck、Johnson & Johnson、Roche、Medtronic ・地域別グローバル市場分析 2015年-2020年 ・1型糖尿病の北米市場（アメリカ、カナダ、メキシコ） ・1型糖尿病のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・1型糖尿病のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・1型糖尿病の南米市場（ブラジル、アルゼンチン） ・1型糖尿病の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：速効性、長時間作用性、プレミックス ・用途別分析：病院、診断クリニック ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Type 1 Diabetes market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Type 1 Diabetes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Type 1 Diabetes market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Type 1 Diabetes market has been segmented into:
Rapid-acting
Long-acting
Premix
By Application, Type 1 Diabetes has been segmented into:
Hospitals
Diagnostic clinics
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Type 1 Diabetes market presented in the report. This section sheds light on the sales growth of different regional and country-level Type 1 Diabetes markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Type 1 Diabetes market.
The report offers in-depth assessment of the growth and other aspects of the Type 1 Diabetes market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Type 1 Diabetes Market Share Analysis
Type 1 Diabetes competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Type 1 Diabetes sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Type 1 Diabetes sales, revenue and market share for each player covered in this report.
The major players covered in Type 1 Diabetes are:
Abbott
AstraZeneca
BD
Bayer
Pfizer
Eli Lilly
Smiths Medical
Merck
Johnson & Johnson
Roche
Medtronic
Table of Contents
1 Type 1 Diabetes Market Overview
1.1 Product Overview and Scope of Type 1 Diabetes
1.2 Classification of Type 1 Diabetes by Type
1.2.1 Global Type 1 Diabetes Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Type 1 Diabetes Revenue Market Share by Type in 2019
1.2.3 Rapid-acting
1.2.4 Long-acting
1.2.5 Premix
1.3 Global Type 1 Diabetes Market by Application
1.3.1 Overview: Global Type 1 Diabetes Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Diagnostic clinics
1.4 Global Type 1 Diabetes Market by Regions
1.4.1 Global Type 1 Diabetes Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Type 1 Diabetes (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Type 1 Diabetes Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Type 1 Diabetes Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Type 1 Diabetes Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Type 1 Diabetes Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Type 1 Diabetes Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Type 1 Diabetes Revenue, Gross Margin and Market Share (2018-2019)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AstraZeneca SWOT Analysis
2.2.4 AstraZeneca Product and Services
2.2.5 AstraZeneca Type 1 Diabetes Revenue, Gross Margin and Market Share (2018-2019)
2.3 BD
2.3.1 BD Details
2.3.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 BD SWOT Analysis
2.3.4 BD Product and Services
2.3.5 BD Type 1 Diabetes Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer SWOT Analysis
2.4.4 Bayer Product and Services
2.4.5 Bayer Type 1 Diabetes Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer SWOT Analysis
2.5.4 Pfizer Product and Services
2.5.5 Pfizer Type 1 Diabetes Revenue, Gross Margin and Market Share (2018-2019)
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Eli Lilly SWOT Analysis
2.6.4 Eli Lilly Product and Services
2.6.5 Eli Lilly Type 1 Diabetes Revenue, Gross Margin and Market Share (2018-2019)
2.7 Smiths Medical
2.7.1 Smiths Medical Details
2.7.2 Smiths Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Smiths Medical SWOT Analysis
2.7.4 Smiths Medical Product and Services
2.7.5 Smiths Medical Type 1 Diabetes Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck SWOT Analysis
2.8.4 Merck Product and Services
2.8.5 Merck Type 1 Diabetes Revenue, Gross Margin and Market Share (2018-2019)
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Johnson & Johnson SWOT Analysis
2.9.4 Johnson & Johnson Product and Services
2.9.5 Johnson & Johnson Type 1 Diabetes Revenue, Gross Margin and Market Share (2018-2019)
2.10 Roche
2.10.1 Roche Details
2.10.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Roche SWOT Analysis
2.10.4 Roche Product and Services
2.10.5 Roche Type 1 Diabetes Revenue, Gross Margin and Market Share (2018-2019)
2.11 Medtronic
2.11.1 Medtronic Details
2.11.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Medtronic SWOT Analysis
2.11.4 Medtronic Product and Services
2.11.5 Medtronic Type 1 Diabetes Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Type 1 Diabetes Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Type 1 Diabetes Players Market Share
3.2.2 Top 10 Type 1 Diabetes Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Type 1 Diabetes Revenue and Market Share by Regions
4.2 North America Type 1 Diabetes Revenue and Growth Rate (2015-2020)
4.3 Europe Type 1 Diabetes Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Type 1 Diabetes Revenue and Growth Rate (2015-2020)
4.5 South America Type 1 Diabetes Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Type 1 Diabetes Revenue and Growth Rate (2015-2020)
5 North America Type 1 Diabetes Revenue by Countries
5.1 North America Type 1 Diabetes Revenue by Countries (2015-2020)
5.2 USA Type 1 Diabetes Revenue and Growth Rate (2015-2020)
5.3 Canada Type 1 Diabetes Revenue and Growth Rate (2015-2020)
5.4 Mexico Type 1 Diabetes Revenue and Growth Rate (2015-2020)
6 Europe Type 1 Diabetes Revenue by Countries
6.1 Europe Type 1 Diabetes Revenue by Countries (2015-2020)
6.2 Germany Type 1 Diabetes Revenue and Growth Rate (2015-2020)
6.3 UK Type 1 Diabetes Revenue and Growth Rate (2015-2020)
6.4 France Type 1 Diabetes Revenue and Growth Rate (2015-2020)
6.5 Russia Type 1 Diabetes Revenue and Growth Rate (2015-2020)
6.6 Italy Type 1 Diabetes Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Type 1 Diabetes Revenue by Countries
7.1 Asia-Pacific Type 1 Diabetes Revenue by Countries (2015-2020)
7.2 China Type 1 Diabetes Revenue and Growth Rate (2015-2020)
7.3 Japan Type 1 Diabetes Revenue and Growth Rate (2015-2020)
7.4 Korea Type 1 Diabetes Revenue and Growth Rate (2015-2020)
7.5 India Type 1 Diabetes Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Type 1 Diabetes Revenue and Growth Rate (2015-2020)
8 South America Type 1 Diabetes Revenue by Countries
8.1 South America Type 1 Diabetes Revenue by Countries (2015-2020)
8.2 Brazil Type 1 Diabetes Revenue and Growth Rate (2015-2020)
8.3 Argentina Type 1 Diabetes Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Type 1 Diabetes by Countries
9.1 Middle East & Africa Type 1 Diabetes Revenue by Countries (2015-2020)
9.2 Saudi Arabia Type 1 Diabetes Revenue and Growth Rate (2015-2020)
9.3 UAE Type 1 Diabetes Revenue and Growth Rate (2015-2020)
9.4 Egypt Type 1 Diabetes Revenue and Growth Rate (2015-2020)
9.5 South Africa Type 1 Diabetes Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Type 1 Diabetes Revenue and Market Share by Type (2015-2020)
10.2 Global Type 1 Diabetes Market Forecast by Type (2019-2024)
10.3 Rapid-acting Revenue Growth Rate (2015-2025)
10.4 Long-acting Revenue Growth Rate (2015-2025)
10.5 Premix Revenue Growth Rate (2015-2025)
11 Global Type 1 Diabetes Market Segment by Application
11.1 Global Type 1 Diabetes Revenue Market Share by Application (2015-2020)
11.2 Type 1 Diabetes Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Diagnostic clinics Revenue Growth (2015-2020)
12 Global Type 1 Diabetes Market Size Forecast (2021-2025)
12.1 Global Type 1 Diabetes Market Size Forecast (2021-2025)
12.2 Global Type 1 Diabetes Market Forecast by Regions (2021-2025)
12.3 North America Type 1 Diabetes Revenue Market Forecast (2021-2025)
12.4 Europe Type 1 Diabetes Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Type 1 Diabetes Revenue Market Forecast (2021-2025)
12.6 South America Type 1 Diabetes Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Type 1 Diabetes Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Type 1 Diabetes Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Type 1 Diabetes by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Type 1 Diabetes Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Type 1 Diabetes Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Corporate Information, Location and Competitors
Table 6. Abbott Type 1 Diabetes Major Business
Table 7. Abbott Type 1 Diabetes Total Revenue (USD Million) (2017-2018)
Table 8. Abbott SWOT Analysis
Table 9. Abbott Type 1 Diabetes Product and Solutions
Table 10. Abbott Type 1 Diabetes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. AstraZeneca Corporate Information, Location and Competitors
Table 12. AstraZeneca Type 1 Diabetes Major Business
Table 13. AstraZeneca Type 1 Diabetes Total Revenue (USD Million) (2018-2019)
Table 14. AstraZeneca SWOT Analysis
Table 15. AstraZeneca Type 1 Diabetes Product and Solutions
Table 16. AstraZeneca Type 1 Diabetes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. BD Corporate Information, Location and Competitors
Table 18. BD Type 1 Diabetes Major Business
Table 19. BD Type 1 Diabetes Total Revenue (USD Million) (2017-2018)
Table 20. BD SWOT Analysis
Table 21. BD Type 1 Diabetes Product and Solutions
Table 22. BD Type 1 Diabetes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bayer Corporate Information, Location and Competitors
Table 24. Bayer Type 1 Diabetes Major Business
Table 25. Bayer Type 1 Diabetes Total Revenue (USD Million) (2017-2018)
Table 26. Bayer SWOT Analysis
Table 27. Bayer Type 1 Diabetes Product and Solutions
Table 28. Bayer Type 1 Diabetes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Pfizer Corporate Information, Location and Competitors
Table 30. Pfizer Type 1 Diabetes Major Business
Table 31. Pfizer Type 1 Diabetes Total Revenue (USD Million) (2017-2018)
Table 32. Pfizer SWOT Analysis
Table 33. Pfizer Type 1 Diabetes Product and Solutions
Table 34. Pfizer Type 1 Diabetes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Eli Lilly Corporate Information, Location and Competitors
Table 36. Eli Lilly Type 1 Diabetes Major Business
Table 37. Eli Lilly Type 1 Diabetes Total Revenue (USD Million) (2017-2018)
Table 38. Eli Lilly SWOT Analysis
Table 39. Eli Lilly Type 1 Diabetes Product and Solutions
Table 40. Eli Lilly Type 1 Diabetes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Smiths Medical Corporate Information, Location and Competitors
Table 42. Smiths Medical Type 1 Diabetes Major Business
Table 43. Smiths Medical Type 1 Diabetes Total Revenue (USD Million) (2017-2018)
Table 44. Smiths Medical SWOT Analysis
Table 45. Smiths Medical Type 1 Diabetes Product and Solutions
Table 46. Smiths Medical Type 1 Diabetes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Merck Corporate Information, Location and Competitors
Table 48. Merck Type 1 Diabetes Major Business
Table 49. Merck Type 1 Diabetes Total Revenue (USD Million) (2017-2018)
Table 50. Merck SWOT Analysis
Table 51. Merck Type 1 Diabetes Product and Solutions
Table 52. Merck Type 1 Diabetes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Johnson & Johnson Corporate Information, Location and Competitors
Table 54. Johnson & Johnson Type 1 Diabetes Major Business
Table 55. Johnson & Johnson Type 1 Diabetes Total Revenue (USD Million) (2017-2018)
Table 56. Johnson & Johnson SWOT Analysis
Table 57. Johnson & Johnson Type 1 Diabetes Product and Solutions
Table 58. Johnson & Johnson Type 1 Diabetes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Roche Corporate Information, Location and Competitors
Table 60. Roche Type 1 Diabetes Major Business
Table 61. Roche Type 1 Diabetes Total Revenue (USD Million) (2017-2018)
Table 62. Roche SWOT Analysis
Table 63. Roche Type 1 Diabetes Product and Solutions
Table 64. Roche Type 1 Diabetes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Medtronic Corporate Information, Location and Competitors
Table 66. Medtronic Type 1 Diabetes Major Business
Table 67. Medtronic Type 1 Diabetes Total Revenue (USD Million) (2017-2018)
Table 68. Medtronic SWOT Analysis
Table 69. Medtronic Type 1 Diabetes Product and Solutions
Table 70. Medtronic Type 1 Diabetes Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Type 1 Diabetes Revenue (Million USD) by Players (2015-2020)
Table 72. Global Type 1 Diabetes Revenue Share by Players (2015-2020)
Table 73. Global Type 1 Diabetes Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Type 1 Diabetes Revenue Market Share by Regions (2015-2020)
Table 75. North America Type 1 Diabetes Revenue by Countries (2015-2020)
Table 76. North America Type 1 Diabetes Revenue Market Share by Countries (2015-2020)
Table 77. Europe Type 1 Diabetes Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Type 1 Diabetes Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Type 1 Diabetes Revenue by Countries (2015-2020)
Table 80. South America Type 1 Diabetes Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Type 1 Diabetes Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Type 1 Diabetes Revenue Market Share by Countries (2015-2020)
Table 83. Global Type 1 Diabetes Revenue (Million USD) by Type (2015-2020)
Table 84. Global Type 1 Diabetes Revenue Share by Type (2015-2020)
Table 85. Global Type 1 Diabetes Revenue Forecast by Type (2021-2025)
Table 86. Global Type 1 Diabetes Revenue by Application (2015-2020)
Table 87. Global Type 1 Diabetes Revenue Share by Application (2015-2020)
Table 88. Global Type 1 Diabetes Revenue Forecast by Application (2021-2025)
Table 89. Global Type 1 Diabetes Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Type 1 Diabetes Picture
Figure 2. Global Type 1 Diabetes Revenue Market Share by Type in 2019
Figure 3. Rapid-acting Picture
Figure 4. Long-acting Picture
Figure 5. Premix Picture
Figure 6. Type 1 Diabetes Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Diagnostic clinics Picture
Figure 9. Global Type 1 Diabetes Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Type 1 Diabetes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Type 1 Diabetes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Type 1 Diabetes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Type 1 Diabetes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Type 1 Diabetes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Type 1 Diabetes Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Type 1 Diabetes Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Type 1 Diabetes Revenue Market Share in 2019
Figure 18. Global Top 10 Players Type 1 Diabetes Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Type 1 Diabetes Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Type 1 Diabetes Revenue Market Share by Regions (2015-2020)
Figure 22. Global Type 1 Diabetes Revenue Market Share by Regions in 2018
Figure 23. North America Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 24. Europe Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 26. South America Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 28. North America Type 1 Diabetes Revenue Market Share by Countries (2015-2020)
Figure 29. North America Type 1 Diabetes Revenue Market Share by Countries in 2019
Figure 30. USA Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 31. Canada Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 33. Europe Type 1 Diabetes Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Type 1 Diabetes Revenue Market Share by Countries in 2019
Figure 35. Germany Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 36. UK Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 37. France Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 38. Russia Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 39. Italy Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Type 1 Diabetes Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Type 1 Diabetes Revenue Market Share by Countries in 2019
Figure 42. China Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 43. Japan Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 44. Korea Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 45. India Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 47. South America Type 1 Diabetes Revenue Market Share by Countries (2015-2020)
Figure 48. South America Type 1 Diabetes Revenue Market Share by Countries in 2019
Figure 49. Brazil Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Type 1 Diabetes Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Type 1 Diabetes Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 54. UAE Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Type 1 Diabetes Revenue and Growth Rate (2015-2020)
Figure 57. Global Type 1 Diabetes Revenue Share by Type (2015-2020)
Figure 58. Global Type 1 Diabetes Revenue Share by Type in 2019
Figure 59. Global Type 1 Diabetes Market Share Forecast by Type (2021-2025)
Figure 60. Global Rapid-acting Revenue Growth Rate (2015-2020)
Figure 61. Global Long-acting Revenue Growth Rate (2015-2020)
Figure 62. Global Premix Revenue Growth Rate (2015-2020)
Figure 63. Global Type 1 Diabetes Revenue Share by Application (2015-2020)
Figure 64. Global Type 1 Diabetes Revenue Share by Application in 2019
Figure 65. Global Type 1 Diabetes Market Share Forecast by Application (2021-2025)
Figure 66. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 67. Global Diagnostic clinics Revenue Growth Rate (2015-2020)
Figure 68. Global Type 1 Diabetes Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Type 1 Diabetes Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Type 1 Diabetes Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Type 1 Diabetes Revenue Market Forecast (2021-2025)
Figure 72. Europe Type 1 Diabetes Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Type 1 Diabetes Revenue Market Forecast (2021-2025)
Figure 74. South America Type 1 Diabetes Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Type 1 Diabetes Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
糖尿病インスリンペンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Diabetes Insulin Pen market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Diabetes Insulin Pen mar…- 糖尿病管理の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Diabetes Management market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 12.9% in the forecast period of 2020 to 2025 and will expected to reach USD 8980.2 million by 2025, from USD 5524.5 million in 2019. The Diabetes Manage…
- 糖尿病管理における人工知能の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Artificial Intelligence in Diabetes Management market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. Th…
- 糖尿病ダイエットの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Diabetes Diet market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Diabetes Diet market report pro…
- ワイヤレス血糖計の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Wireless Blood Glucose Meter market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Wireless Blood G…